CCL4 and COVID-19: We also did not detect an increase in CCL3 and CCL4 antibodies in COVID-19 convalescents compared with healthy controls in the Lugano cohort at month 6, although the amount of corresponding chemokines was elevated in their plasma (Fig. 3a and Extended Data Fig. 5a).